EGFR and breast carcinoma: In addition, a study by Vivacqua and colleagues [87] indicated that the expression of EGR-1 was induced in response to E2 and tamoxifen in ERα66-negative SKBr3 breast cancer cells in a GPER-EGFR-ERK-dependent manner.